focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Share News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 440.00
Bid: 430.00
Ask: 450.00
Change: 0.00 (0.00%)
Spread: 20.00 (4.651%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 440.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tristel lauds 'milestone' as products receive Chinese and Korean approval

Mon, 01st Apr 2019 16:46

(Sharecast News) - Tristel on Monday received approval for its Duo High-Level disinfectant and its Sporicidal Wipe from regulatory bodies in China and South Korea, respectively.The infection prevention and contamination control products manufacturer said it has a well-established presence in both China and South Korea, and will use its own sales force to sell Duo in China, while in South Korea the Sporicidal Wipe will go through its distributor, HP&C Ltd.Paul Swinney, chief executive of Tristel, said: "Every regulatory approval we achieve represents an important milestone in our progress, but these two approvals have special significance. Duo ULT provides Chinese public hospitals with an affordable and easy-to-use method for the high-level disinfection of intra-vaginal ultrasound probes. Infection prevention experts within the country acknowledge the need for a disinfection technology that will enable hospitals to raise their standards to those commonplace elsewhere."Both of the products are widely used throughout Europe, the Middle East and the Asia-Pacific region, and the AIM traded company said sales of chlorine dioxide foam and wipe products for medical device disinfection came in at £8.6m for the six-month period ending 31 December, representing an increase of 23% on the corresponding period in the previous year."In South Korea our chlorine dioxide technology has had to achieve approval as a new drug and the process has taken over four years. Our distributor is optimistic for the future long-term prospects of our technology in the South Korean hospital market," said Swinney.Tristel's shares were up 3.68% at 285.11p at 1647 BST.
More News
11 Jun 2018 16:11

DIRECTOR DEALINGS: Tristel Non-Executive Paul Barnes Sells Shares

LONDON (Alliance News) - Tristel PLC on Monday said Non-Executive Director Paul Barnes sold shares in the decontamination firm.In a transaction on Friday, Barnes disposed 15,000 shares at a

Read more
1 Jun 2018 16:53

DIRECTOR DEALINGS: Tristel Chairman Sells Shares And Director Buys

LONDON (Alliance News) - Tristel PLC, which produces contamination control and hygiene products, said Non-Executive Director David Orr purchased 7,000 shares at a price of 306.05 pence per share a

Read more
11 May 2018 17:54

DIRECTOR DEALINGS: Tristel Chief Executive Officer Sells 15,000 Shares

LONDON (Alliance News) - Tristel PLC said Friday that its Chief Executive Officer Paul Swinney sold 15,000 shares.Swinney sold the hygiene product manufacturer shares for 315 pence, a total

Read more
26 Mar 2018 15:39

Tristel Agrees Manufacturing Deal With US Firm Parker Laboratories

LONDON (Alliance News) - Infection prevention product maker Tristel PLC said Monday it has signed a manufacturing and marketing deal with Parker Laboratories Inc in the the on

Read more
6 Dec 2016 08:01

Tristel to issue shares pursuant to exercise of stock options

(ShareCast News) - Tristel said it had issued shares the day before pursuant to the exercise of stock options in the company. On Monday, the manufacturer of infection prevention and contamination control products said it issued 25,500 shares at 1p each and had applied for them to be admitted to trad

Read more
17 Oct 2016 08:11

Tristel Profit Flat As One-Offs Offset Revenue Growth, Dividend Hiked

Read more
17 Oct 2016 08:01

Tristel's turnover increases as it continues North American expansion plan

(ShareCast News) - AIM-listed Tristel, a manufacturer of infection prevention products, increased turnover while it continues to expand globally, particularly in North America. For the year ended 30 June, turnover rose 12% to £17.1m, compared to the previous year, which was ahead of market expectati

Read more
11 Oct 2016 15:05

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
11 Oct 2016 11:41

Tristel product comes out on top in New Zealand study

(ShareCast News) - Infection prevention, contamination control and hygiene products manufacturing company Tristel announced on Tuesday that in a randomised, single-blind comparison of disinfectants used in ear, nose and throat clinics conducted by a public health authority in New Zealand, its Wipes

Read more
11 Oct 2016 08:37

Tristel Hails Study Showing Wipes System Equal To DuPont, J&J Products

Read more
21 Jul 2016 12:07

Tristel buys Aussie rival Ashmed as it reports 'strong' growth

(ShareCast News) - Hygiene product manufacturer Tristel on Thursday announced it has bought the business and assets of its Australian competitor as the group declared a special dividend after "strong" second half growth. The AIM listed company said in a trading update it bought the business and asse

Read more
21 Jul 2016 08:19

Tristel To Pay Special Dividend As Profit Grows; Buys Distributor

Read more
29 Apr 2016 10:26

DIRECTOR DEALINGS: Tristel Chairman Soler Buys More Shares

Read more
26 Apr 2016 10:42

DIRECTOR DEALINGS: Tristel CEO Swinney Buys 5,000 Shares

Read more
15 Mar 2016 11:12

DIRECTOR DEALINGS: Tristel Chairman Soler Adds To 26% Stake

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.